TeLIPro Health Program - Active With Diabetes

Summary

In a randomized-controlled trial the hypothesis should be tested that the Telemedical Lifestyle Intervention Program TeLIPro could significantly improve HbA1c (primary outcome), body weight and composition, cardiovascular risk factors, quality of life, eating behavior, and medication demand (secondary outcomes) in type 2 diabetes mellitus (T2DM) patients.

Conditions

• Diabetes Mellitus, Type 2

Interventions

DEVICE

Scale

self-monitoring of body weight; with automatic data transfer into the personalized and secured online portal

DEVICE

Step counter

self-monitoring of physical activity; with automatic data transfer into the personalized and secured online portal

DEVICE

Blood glucose meter with test stripes

self-monitoring of blood glucose; with automatic data transfer into the personalized and secured online portal

OTHER

Access to the online portal

self-monitoring of health parameters

OTHER

Telemedical coaching

regular telephone calls providing information about T2DM, healthy lifestyle, low-carbohydrate diet and physical activity

Sponsors & Collaborators

• AOK Rheinland/Hamburg

  collaborator INDUSTRY

• German Institute for Telemedicine and Health Promotion

  collaborator OTHER

• German Diabetes Center

  collaborator OTHER

• West German Center of Diabetes and Health

  lead OTHER

Principal Investigators

• Bernd Altpeter · Deutsches Institut für Telemedizin und Gesundheitsförderung

• Sibel Altin · AOK Rheinland/Hamburg

• Andrea Icks, PhD · Deusches Diabetes Zentrum

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

25 Years

Max Age

79 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-09-15

Primary Completion

2021-09-21

Completion

2022-09-30

Countries

• Germany

Study Locations